A common protocol involves administering 1,000 mcg of B12 weekly for 4 to 8 weeks, depending on the deficiencys severity and the patients response
Sao Paulo Medical Journal = Revista Paulista de Medicina
At our London, ON - North clinic, we assess your symptoms, health history, and hormone levels to determine if GHRH therapy is appropriate for your goals
Current Good Manufacturing Practice (CGMP) Regulations
Nervous system Very common (10% or more): Dysesthesia (up to 22%), headache (up to 17%) Common (1% to 10%): Dizziness, dysgeusia Uncommon (0.1% to 1%): Syncope Postmarketing reports : Headache, dizziness, dysgeusia, dysesthesia Dysesthesia included allodynia, burning sensation, hyperesthesia, hyperpathia, pain of skin, paresthesia, sensitive skin, skin burning sensation, skin discomfort, and skin sensitization